glp 1 long term risks Addressing patient concerns about the 'newness' and long-term safety of GLP- receptor agonists: A clinician's guide to counseling GLP-1 for Prevention: Using Drugs

7,11 Steroid-induced hypertension has been observed in up to 20% of Cushing syndrome patients and is largely dose-dependent

Confirmation the patient is not receiving PBS-subsidised SGLT2-i, DPP-4 i, or another GLP-1 RA.

Iacobellis G, Villasante Fricke AC (2020) Effects of semaglutide versus dulaglutide on epicardial fat thickness in subjects with type 2 diabetes and obesity

78 The average half-life of exenatide is 2.4 h, 2 to 3 times per day

GLP-1s for Osteoarthritis GLP-1 drugs may slow the progression of osteoarthritis, as research has found that people on the drugs lost more weight and had fewer knee surgeries than people not taking a GLP-1

Important information Learn to inject Need help